PUBLISHER: The Business Research Company | PRODUCT CODE: 1948634
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948634
Vitreoretinal surgery devices are specialized medical instruments that typically incorporate a peristaltic pump, a venturi pump, or a combination of both to manage fluids. They play a crucial role in core vitrectomy removal, membrane cutting, and addressing hyaloid and vitreous bases during surgical procedures. These vitreoretinal surgical instruments are designed with enhanced flow control features, aiming to minimize retinal traction.
The primary product types within the vitreoretinal surgery devices category include photocoagulation lasers, illumination devices, vitrectomy machines, vitrectomy probes, vitreoretinal packs, and others. Photocoagulation lasers are medical devices utilized to either shrink or eliminate abnormal structures in the retina. Surgical approaches encompass both anterior vitreoretinal surgery and posterior vitreoretinal surgery, addressing applications such as diabetic vitreous hemorrhage, retinal detachment, macular hole, among others. These devices find application across various end-users, including hospitals, specialty clinics, ambulatory surgery centers, and others.
Tariffs are influencing the vitreoretinal surgery devices market by increasing costs of imported probes, lasers, illumination components, pumps, and electronic control systems used in advanced retinal surgeries. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported high-value devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are elevating equipment acquisition expenses and slowing upgrade cycles. However, they are also supporting local device manufacturing, regional supplier ecosystems, and innovation in cost-optimized vitreoretinal surgical technologies.
The vitreoretinal surgery devices market research report is one of a series of new reports from The Business Research Company that provides vitreoretinal surgery devices market statistics, including vitreoretinal surgery devices industry global market size, regional shares, competitors with a vitreoretinal surgery devices market share, detailed vitreoretinal surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the vitreoretinal surgery devices industry. This vitreoretinal surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vitreoretinal surgery devices market size has grown strongly in recent years. It will grow from $2.13 billion in 2025 to $2.26 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to expansion of vitreoretinal surgical procedures, increasing prevalence of diabetic eye diseases, rising adoption of modern ophthalmic equipment, improved surgeon training programs, availability of advanced surgical probes.
The vitreoretinal surgery devices market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for precision retinal surgeries, rising investments in ophthalmic innovation, expansion of ambulatory surgery centers, growing focus on patient safety outcomes, increased adoption of digitally assisted surgery. Major trends in the forecast period include increasing use of advanced fluid control systems, rising adoption of integrated vitreoretinal platforms, growing demand for high-speed vitrectomy probes, expansion of single-use surgical accessories, enhanced focus on reduced retinal trauma.
The rising number of minimally invasive surgeries is expected to drive the growth of the vitreoretinal surgery devices market. Minimally invasive surgeries (MIS) are procedures designed to achieve therapeutic outcomes while reducing trauma to the body. Vitreoretinal surgery devices enable precise interventions within the eye through small incisions, improving visualization, supporting delicate procedures, and contributing to faster recovery times. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based specialty organization, minimally invasive procedures grew by 7 percent in 2023, outpacing surgical procedures by 2 percent, with neuromodulator injections and hyaluronic acid fillers each exceeding 9 million and 5 million treatments, respectively.
Major companies in the vitreoretinal surgery devices market are focusing on advanced solutions such as integrated surgical platforms to enhance surgical precision, efficiency, and patient outcomes. Integrated surgical platforms combine fluidics, high-speed cutting, micro-injection, and a variety of instruments into a unified workflow, enabling surgeons to perform complex procedures with better accuracy and control. For instance, in October 2024, Carl Zeiss Meditec AG, a Germany-based medical technology company, expanded its D.O.R.C. EVA NEXUS vitreoretinal surgical system as part of the ZEISS Retina Workflow at AAO 2024. The system incorporates a VTi pump with advanced FLOW & VACUUM fluidics, a TDC vitrectomy cutter capable of up to 20,000 cuts per minute, the EVA INICIO micro-injection system, and a range of posterior instruments including 27G ULTRA tools and surgical liquids/tamponades, designed to streamline vitreoretinal surgeries and improve clinical decision-making.
In April 2024, Carl Zeiss Meditec AG acquired Dutch Ophthalmic Research Center (D.O.R.C.) for an undisclosed amount. The acquisition broadens Carl Zeiss Meditec's ophthalmic portfolio, strengthens its presence in the vitreoretinal surgery segment, and expands its integrated digital workflow capabilities across retina and cataract procedures. D.O.R.C., based in the Netherlands, provides advanced vitreoretinal surgical platforms, instruments, consumables, and ophthalmic surgical solutions for retina and combined cataract surgeries.
Major companies operating in the vitreoretinal surgery devices market are Alcon Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., D.O.R.C. Dutch Ophthalmic Research Center B.V., Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers Ltd, Geuder AG, BVI Medical Inc., MedOne Surgical Inc., Oculus Optikgerate GmbH, Inami & Co. Ltd, Hoya Corporation, Nidek Co. Ltd, Leica Microsystems GmbH, Katalyst Surgical LLC, Synergetics USA Inc., Lumenis Ltd, Optos plc, Alimera Sciences Inc., Oertli Instrumente AG, MicroSurgical Technology Inc
North America was the largest region in the vitreoretinal surgery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global vitreoretinal surgery devices market report during the forecast period. The regions covered in the vitreoretinal surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vitreoretinal surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vitreoretinal surgery devices market consists of sales squeezers, luer locks, forceps, and surgical instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vitreoretinal Surgery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vitreoretinal surgery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vitreoretinal surgery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vitreoretinal surgery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.